The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Boric acid - Sodium tetraborate buffer solution Drug Master File in Japan (Boric acid - Sodium tetraborate buffer solution JDMF) empowers Boric acid - Sodium tetraborate buffer solution API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Boric acid - Sodium tetraborate buffer solution JDMF during the approval evaluation for pharmaceutical products. At the time of Boric acid - Sodium tetraborate buffer solution JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Boric acid - Sodium tetraborate buffer solution suppliers with JDMF on PharmaCompass.